Weixian Yang

Weixian Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
HZHan Zhang
Han Zhang
YZYin Zhang
Yin Zhang
TTTao Tian
Tao Tian
TWTianjie Wang
Tianjie Wang
JCJue Chen
Jue Chen
LSLei Song
Lei Song

11 August 2022 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
WCWentian Cai
Wentian Cai
LXLinsen Xie
Linsen Xie
WYWeixian Yang
Weixian Yang
YLYijiang Li
Yijiang Li
Gao YingGao Ying
Gao Ying
TWTingting Wang
Tingting Wang
Medical image segmentation has long suffered from the problem of expensive labels. Acquiring pixel-level annotations is time-consuming, labor-intensive, and relies on extensive expert knowledge. Bounding box annotations, in contrast, are relatively easy to acquire. Thus, in this paper, we explore to segment images through a novel Dual-path Feature Transfer design with only bounding box annotations. Specifically, a Target-aware Reconstructor is proposed to extract target-related features by reconstructing the pixels within the bounding box through the channel and spatial attention module. Then, a sliding Feature Fusion and Transfer Module (FFTM) fuses the extracted features from Reconstructor and transfers them to guide the Segmentor for segmentation. Finally, we present the Confidence Ranking Loss (CRLoss) which dynamically assigns weights to the loss of each pixel based on the network's confidence. CRLoss mitigates the impact of inaccurate pseudo-labels on performance. Extensive experiments demonstrate that our proposed model achieves state-of-the-art performance on the Medical Segmentation Decathlon (MSD) Brain Tumour and PROMISE12 datasets.

27 July 2023 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Open access
PDF file
HWHuanhuan Wang
Huanhuan Wang
CCCheng Cui
Cheng Cui
HLHaiming Liu
Haiming Liu
BZBo Zhang
Bo Zhang
TTTao Tian
Tao Tian
LGLijian Gao
Lijian Gao
Purpose: Radial artery occlusion (RAO) is an unresolved complication after transradial artery (TRA) puncture. The aim of this observational study was to assess the feasibility and safety of retrograde recanalization of RAO through distal transradial access (dTRA). Methods: From June 2021 to March 2022, 28 consecutive patients with successful puncture and intubation through the dTRA in the anatomical snuffbox and RAO confirmed by angiography were enrolled. Results: Among the 28 patients, 27 (96.4%) patients with RAO were successfully retrogradely recanalized through the dTRA and successfully underwent coronary angiography or coronary intervention. After the procedure, only 1 (3.7%) patient developed a forearm hematoma, and there were no other bleeding complications or nerve disorders. Conclusions: DTRA is a safe and feasible approach for retrograded recanalization of RAO, with a high procedure success rate and few complications.

31 July 2024 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
BFBingqi Fu
Bingqi Fu
YZYan Zeng
Yan Zeng
MWMan Wang
Man Wang
LZLin Zhao
Lin Zhao
LSLin Sun
Lin Sun
WHWei Hua
Wei Hua
Background: The association between the triglyceride-glucose (TyG) index and clinical outcomes in patients with both coronary artery disease (CAD) and psoriasis is unclear. This study investigated the association between the TyG index and major adverse cardiovascular events (MACE) in patients with both CAD and psoriasis. Methods: This retrospective cohort study included patients diagnosed with both CAD and psoriasis who underwent coronary angiography at the Fuwai Hospital, Beijing, China, between January 2017 and May 2022. The study endpoint was the occurrence of MACE or end of follow-up time. Multivariate Cox proportional analysis and restricted cubic splines (RCS) were used to determine the association between the TyG index and MACE. Receiver operating characteristic (ROC) curves were used to determine the optimal threshold value of the TyG index for predicting MACE. Results: This study enrolled 293 patients with both CAD and psoriasis, including 258 (88.1%) males with a mean age of 58.89 ± 9.61 years. Patients were divided into four groups based on the TyG quartiles: Q1 (N = 74), Q2 (N = 73), Q3 (N = 73), and Q4 (N = 73). After adjusting for the potential confounders, the TyG index was independently associated with MACE, both as a continuous variable (HR = 1.53, 95% CI = 1.03–2.28, P = 0.035) and as a categorical variable (Q1: reference; Q2: HR = 1.85, 95% CI = 0.88–3.87, P = 0.105; Q3: HR = 2.39, 95% CI = 1.14-5.00, P = 0.021; Q4: HR = 2.19, 95% CI = 1.001–4.81, P = 0.0497; P for trend = 0.039). RCS analysis showed an linear association between the TyG index and MACE (P-overall = 0.027, P-non-linear = 0.589). ROC curve analysis showed that the TyG index of ≥ 8.73 was the optimal threshold value (area under the ROC curve = 0.60, 95% CI 0.53–0.67). TyG index ≥ 8.73 was significantly associated with MACE (HR = 2.10, 95% CI = 1.32–3.34, P = 0.002). After adjustment for confounders, the TyG index showed independent association with MACE (HR = 2.00, 95% CI = 1.17–3.42, P = 0.011). Conclusions: The TyG index showed a positive linear correlation with MACE in patients with both CAD and psoriasis. The TyG index of ≥ 8.73 might be the optimal threshold for predicting MACE. Graphical

2 September 2023 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
LZLin Zhao
Lin Zhao
LSLin Sun
Lin Sun
ZZZengLei Zhang
ZengLei Zhang
KYKunQi Yang
KunQi Yang
ZLZuoZhi Li
ZuoZhi Li
WYWeixian Yang
Weixian Yang
Background: The prognostic value of lipoprotein (Lp) (a) in patients who have suffered from coronary artery disease (CAD) has not been fully studied, and the results are inconsistent. This study was conducted to evaluate whether increased Lp(a) concentrations cause differences in clinical adverse outcomes in patients with psoriasis who have already suffered from CAD. Methods: This retrospective cohort study included consecutive patients with psoriasis and CAD between January 2017 and May 2022 in our hospital. The clinical records were collected, and comparisons were made between patients in the low Lp(a) and high Lp(a) groups. Cox proportional hazard analysis and log-rank tests were used to evaluate the association between variables. Results: Among 295 patients, 148 patients were in the low Lp(a) group, and 147 were in the high Lp(a) group. These two groups did not differ significantly in age, gender or body mass index. Compared with the low Lp(a) group, the levels of platelet counts (P = 0.038) and high sensitivity C reactive protein (P = 0.012) were higher in the high Lp(a) group. Patients in the high Lp(a) group had higher total cholesterol levels (P = 0.029) and lower triglyceride levels (P = 0.037). Among the whole cohort, clinical adverse events were not correlated with Lp(a) concentrations after a median follow-up of 3 years. However, in the subgroup analysis, there were significant differences in all-cause death (log rank P = 0.036) and rehospitalization (log rank P = 0.037) between the two groups in patients with diabetes; a difference in rehospitalization (log rank P = 0.042) was also found between the two groups in men. Conclusions: In patients with psoriasis and CAD, high levels of Lp(a) were related to a poor prognosis, especially in patients with diabetes and in men. These results will provide valuable information for the risk stratification of patients with psoriasis and CAD.

1 September 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
LZLin Zhao
Lin Zhao
YZYan Zeng
Yan Zeng
LSLin Sun
Lin Sun
ZZZengLei Zhang
ZengLei Zhang
KYKunQi Yang
KunQi Yang
WYWeixian Yang
Weixian Yang
Purpose: The presence of elevated fibrinogen levels is associated with cardiovascular disease. However, whether fibrinogen level is associated with adverse clinical events in patients with psoriasis and coronary artery disease (CAD) is unknown. This study aimed to investigate the relationship between fibrinogen levels and cardiovascular adverse events in these patients. Patients and Methods: This retrospective cohort study collected consecutive patients with psoriasis and CAD between January 2017 and May 2022 in our hospital. The clinical records were collected, and comparisons were made between groups. The Cox regression analysis and Kaplan–Meier survival analysis were used to evaluate the association between variables. Results: Of the 267 participants, one hundred and forty-seven patients (55.1%) had elevated fibrinogen levels. Compared with patients in low fibrinogen group, white blood cell and platelet counts and high-sensitivity C-reactive protein levels were higher, whereas the left ventricular ejection fraction was lower in patients in high fibrinogen group. After a median follow-up of 35.5 months, the incidence of major adverse cardiovascular events (MACEs) was higher in patients in high fibrinogen group compared with patients in low fibrinogen group (31.4% vs 16.4%, p = 0.013). The Kaplan–Meier survival curves showed the same trend (log rank p = 0.020). Subgroup analysis revealed a positive association between elevated fibrinogen levels and MACEs in patients aged < 60 years (log-rank p = 0.013), those with diabetes (log-rank p = 0.027), and those who were not admitted for acute cardiovascular syndrome (log-rank p = 0.015). Conclusion: Elevated fibrinogen levels were associated with adverse clinical events in patients with psoriasis and CAD, especially among patients aged < 60 years, those with diabetes, and those not admitted for acute cardiovascular syndrome.